<p>TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. </p>

TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.

<p>TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.&nbsp;</p>

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Share TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

Sign up to save your podcasts

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials